Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Minoxidil works better for female hair loss, but cyproterone reduces scalp oiliness and causes menstrual issues.

Alopecia areata is a type of hair loss that can lead to complete baldness, often associated with other autoimmune conditions, and half of the cases may see hair return within a year.

Low-Level Laser Therapy (LLLT) is a safe and effective treatment for common hair loss, but more research is needed to find the best power and wavelength for treatment.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Topical Minoxidil effectively and safely regrows hair in cancer patients.

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

Alopecia areata causes patchy hair loss due to unknown factors, affecting all ages and genders.

PRP injections significantly improve hair regrowth in alopecia areata.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

Minoxidil is better for female hair loss without hormonal issues, cyproterone acetate for those with; people with treated congenital heart disease have lower life quality; personality differs in types of infertility; oral terbinafine is best for toenail fungus; bladder training reduces incontinence; nurse clinics help with heart disease; weight loss improves body composition and liver disease; computer training cuts drug errors.

Hair transplantation effectively treats burn scar alopecia, improving self-esteem and confidence.

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Frontal fibrosing alopecia can sometimes look like syphilitic hair loss.

Scalp cooling effectively prevents hair loss in breast cancer patients undergoing chemotherapy.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Minoxidil promotes hair growth in women with early-stage alopecia.

Valproic acid increases hair count in men with hair loss.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Frontal Fibrosing Alopecia in men is often missed and can come with symptoms like facial bumps and hair loss on eyebrows and limbs.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.